Evidence map›Paper›PMID 24166775›Full record

ArticlePediatric pulmonology2014

Tracheomalacia is associated with lower FEV1 and Pseudomonas acquisition in children with CF.

Anthony J Fischer, Sachinkumar B Singh, Ryan J Adam, David A Stoltz, Christopher F Baranano, Simon Kao, Miles M Weinberger, Paul B McCray, Timothy D Starner

Abstract read
In one paragraph

Article in Pediatric pulmonology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Considerations for early life genetic therapies in cystic fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  2. Systemic in utero gene editing as a treatment for cystic fibrosis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Genome-wide association study of susceptibility toThe European respiratory journal · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Successful biodegradable stent insertion in an infant with severe bronchomalacia and cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  12. Article
  13. Review
  14. Lack of cystic fibrosis transmembrane conductance regulator disrupts fetal airway development in pigs.Laboratory investigation; a journal of technical methods and pathology · 2018
    Article
  15. Review
  16. Review
  17. Postnatal airway growth in cystic fibrosis piglets.Journal of applied physiology (Bethesda, Md. : 1985) · 2017
    Article
  18. Article
  19. Best practices in the treatment of early cystic fibrosis lung disease.Therapeutic advances in respiratory disease · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Anthony J FischerDepartment of Pediatrics, University of Iowa, Iowa City, Iowa.
Sachinkumar B Singh
Ryan J Adam
David A Stoltz
Christopher F Baranano
Simon Kao
Miles M Weinberger
Paul B McCray
Timothy D Starner
University of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Respiratory virus infection in early cystic fibrosis lung diseaseP01HL091842 · NHLBI · UNIVERSITY OF IOWA · PI STOLTZ, DAVID A · 2008 to 2022
$34.2M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Multidisciplinary Lung Research Career Development ProgramT32HL007638 · NHLBI · UNIVERSITY OF IOWA · PI WELSH, MICHAEL J., ZABNER, JOSEPH · 1986 to 2020
$16.9M
NHLBI NIH HHS P01 HL091842NHLBI NIH HHS T32 HL007638NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

backgroundTracheomalacia (TM) occurs in approximately 1 in 2,100 children. Because the trachea develops abnormally in animal models of cystic fibrosis (CF), we hypothesized this may also occur in children with CF, increasing their risk of TM. PURPOSE: To examine the prevalence and clinical consequences of TM in children with CF.

methodsWe studied children with CF born between 1995 and 2012. TM was defined as dynamic collapse of the trachea, and the severity was recorded as described in the chart. The effect of TM on patient outcomes, including FEV1 , CT changes, and acquisition of CF pathogens, was assessed using a longitudinal patient dataset.

resultsEighty-nine percent of children with CF had at least one bronchoscopy (n = 97/109). Fifteen percent of these children had TM described in any bronchoscopy report (n = 15/97). Of the patients with TM, eight had meconium ileus (P = 0.003) and all were pancreatic insufficient. Pseudomonas aeruginosa infection occurred 1.3 years earlier among children with TM (P = 0.01). Starting FEV1 values by age 8 were diminished by over 18% of predicted for patients with TM. Life-threatening episodes of airway obstruction occurred in 3 of 15 patients with CF and TM, including one leading to death. Gender, prematurity, and hepatic disease were not associated with TM. No difference was observed in the frequency of bronchiectasis.

conclusionsTM is significantly more common in infants and children with CF than in the general population and is associated with airway obstruction and earlier Pseudomonas acquisition.

Indexed as

Forced Expiratory VolumeAirway ObstructionCohort StudiesCystic FibrosisFemaleHumansInfantMalePseudomonas InfectionsRetrospective StudiesTracheomalaciaairwaybronchoscopycystic fibrosisinfantmeconium ileusobstructive lung diseasepediatrictracheomalacia

Identifiers

PMID24166775
PMCPMC4711356
OpenAlexW2123492716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.